Data processing: measuring – calibrating – or testing – Measurement system in a specific environment – Biological or biochemical
Reexamination Certificate
2003-12-11
2010-06-08
Skowronek, Karlheinz R (Department: 1631)
Data processing: measuring, calibrating, or testing
Measurement system in a specific environment
Biological or biochemical
C702S020000
Reexamination Certificate
active
07734421
ABSTRACT:
A method for identifying a motif or a combination of motifs having a Boolean state of predetermined mutations in a set of sequences including a) aligning a set of sequences of ordered motifs represented by a single-character code, b) comparing a reference sequence with the set of sequences aligned in step (a), c) identifying motifs not having mutated simultaneously or motifs having mutated simultaneously at least once on at least one sequence of the set and not having mutated on another sequence of the set.
REFERENCES:
patent: WO 99/61658 (1999-12-01), None
Rose et al. (Bioinformatics, vol. 16, No. 4, p. 400-401, 2000).
Strimmer et al. (PNAS vol. 94, p. 6815-6819, Jun. 1997).
Caride et al. (Journal of Clinical Virology, vol. 23, p. 179-189, 2002).
Korber et al. (PNAS, vol. 90, p. 7176-7180, Aug. 1, 1993).
Collins et al. (Chapter 13: molecular sequence comparisons and alignment In Nucleic acid and protein sequence analysis, IRL Press, ed. Bishop and Rawlings, p. 232-358, 1987).
Zhang et al (New England Journal of Medicine, vol. 340, No. 21, p. 1605-1613, May 27, 1999).
Thompson et al (Nucleic Acids Research, vol. 22, No. 22, p. 4673-4680, 1994).
Eddy (Trends Guide to Bioinformatics, 15-18, 1998, (preprint), [online] available at selab.janelia.org/publications.html).
Robert W. Shafer et al.,Human immunodeficiency virus type 1 reverse transcriptase and protease mutation search engine for queries, Nature Medicine, vol. 6, No. 11, Nov. 2000, pp. 1290-1292.
Rami Kantor et al.Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database: an expanded data model integrating natural language text and sequence analysis programs, Nucleic Acids Research, vol. 29, No. 1, Jan. 2001, pp. 296-299.
Robert W. Shafer et al.,Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database, Nucleic Acids Research, vol. 28, No. 1, Jan. 2000, pp. 346-348.
Robert W. Shafer et al.,Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database, Nucleic Acids Research, vol. 27, No. 1, Jan. 1999, pp. 348-352.
Eddy, S., “Hidden Markov models,” Curr. Opin. Struct. Biol., vol. 6., pp. 361-365, 1996.
Laurent-Puig, P. et al., “APC gene database of germline and somatic mutations in human tumors and cell lines,” Nucleic Acids Res Jan. 1, 1998; 26(1) pp. 269-270.
Beroud, C. et al., “p53 and APC gene mutations software and databases,” Nucleic Acids Res Jan. 1, 1997; 25(1), p. 138.
Papillon, E. et al., “A malignant gastrointestinal stromal tumor in a patient with multiple endocrine neoplasis type 1,” European Journal of Gastroenterology & Hepatology, 2001, 13:207-211.
Gallou, C. et al., “Mutations of the VHL Gene in Sporadic Renal Cell Carcinoma Definition of Risk Factor for VHL Patients to Develop an RCC,” Human Mutation, 13:464-475 (1999) .
Baudry, D, et al., “WTI Splicing Alterations in Wilms' Tumors,” Clin Cancer Res Oct. 6, 2000;(10): pp, 3957-3965.
Hammond, J. et al., “Mutations in Retroviral Genes Associated with Drug Resistance,” The Human Retrovirus and AIDS Compendium, 1999, pp. 542-591.
Chou, K.C., “Prediction of Human Immunodeficiency Virus Protease Cleavage Sites in Proteins,” Anal. Biochem. 1996, 233, pp. 1-14.
Draghiei, S. et al., “Predicting HIV drug resistance with neural networks,” Bioinformatics, 19(1), 2003. pp. 98-107.
Wesche, P. et al., “DNA Sequence Error Rates in GenBank Records Estimated using the Mouse Genome as a Reference,” DNA Sequence, 2004, vol. 15 (5/6), pp. 362-364.
Lawrence, C. et al., “Assignment of position-specific error probability to primary DNA sequence data,” Nucleic Acids Research, 1994, vol. 22(7), pp. 1272-1280.
Muller-Trutwin Michaela
Valère Thomas
Vanet Anne
Centre National de la Recherche Scientifique "CNRS"
DLA Piper (LLP) US
Skowronek Karlheinz R
LandOfFree
Method for identifying motifs and/or combinations of motifs... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for identifying motifs and/or combinations of motifs..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for identifying motifs and/or combinations of motifs... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4216374